Ozempic for Women: Hormones & Menstrual Changes (2026)

Women make up the majority of semaglutide users, yet much of the public conversation focuses on broadly applicable data. Here is a women-specific breakdown of what to expect, what to watch for, and how to optimise results.

Do Women Respond Differently to Semaglutide?

Clinical trial data shows similar average weight loss between men and women at the same doses. However there is greater individual variability in women, partly due to hormonal influences on metabolism, baseline insulin sensitivity differences, and how body fat distribution differs between sexes. Some women significantly outperform the average — losing 25–35% of body weight — while others respond more modestly.

Hormonal Interactions

Semaglutide does not directly alter oestrogen or progesterone levels. However, significant weight loss does affect hormonal balance — reducing levels of adipokines produced by fat tissue, and often improving hormonal markers in conditions like PCOS. Women who lose substantial weight on semaglutide often report improvements in hormonal symptoms including acne, excess body hair (hirsutism), and menstrual regularity.

Birth Control: An Important Consideration

Semaglutide slows gastric emptying — the rate at which your stomach passes content to the intestine. Oral contraceptive pills (the combined pill, mini pill) are absorbed in the small intestine, and slowed gastric emptying can reduce their absorption and potentially reduce their effectiveness. Most prescribers advise women on oral contraceptives to either switch to a non-oral method (implant, injection, IUD, patch, ring) or use barrier contraception alongside the pill for the first 28 days after each dose increase. After reaching a stable dose, oral contraceptive absorption generally normalises. This is an important conversation to have with your prescriber before starting semaglutide.

Menstrual Cycle Changes

Irregular periods, lighter cycles, or temporary changes in cycle length are commonly reported by women in the first months of semaglutide treatment. This is largely attributable to the metabolic and hormonal effects of rapid weight loss — the body is adjusting to a significant change in fat mass, which is an endocrine organ. These changes typically resolve as weight stabilises. Women with PCOS often experience the opposite effect — irregular cycles becoming more regular as insulin resistance improves and androgen levels normalise.

Muscle Preservation: Especially Important for Women Over 40

Women naturally have less muscle mass than men, and oestrogen decline in perimenopause and menopause further accelerates muscle loss during caloric restriction. On semaglutide, without adequate protein intake and resistance training, a higher proportion of weight lost can be muscle rather than fat. The recommendations are the same as for all users but are especially critical for women over 40: aim for 100–130g of protein daily, and perform at least 2–3 resistance training sessions per week.

Fertility Considerations

Semaglutide is not recommended during pregnancy or while trying to conceive. It should be discontinued at least 2 months before attempting conception. Paradoxically, for women with PCOS-related infertility, semaglutide may improve ovulatory function and insulin sensitivity in the months before discontinuation — potentially improving fertility prospects. This should be discussed in detail with a reproductive endocrinologist.

Affiliate disclosure: This article contains affiliate links. See our Affiliate Disclosure.